These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10400020)

  • 1. Gender differences in molecular remodeling in pressure overload hypertrophy.
    Weinberg EO; Thienelt CD; Katz SE; Bartunek J; Tajima M; Rohrbach S; Douglas PS; Lorell BH
    J Am Coll Cardiol; 1999 Jul; 34(1):264-73. PubMed ID: 10400020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
    J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of pressure overload-induced left ventricular hypertrophy in mice.
    Gao XM; Kiriazis H; Moore XL; Feng XH; Sheppard K; Dart A; Du XJ
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2702-7. PubMed ID: 15665058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.
    Chang KC; Figueredo VM; Schreur JH; Kariya K; Weiner MW; Simpson PC; Camacho SA
    J Clin Invest; 1997 Oct; 100(7):1742-9. PubMed ID: 9312172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent heart compared with pressure overload-induced hypertrophy.
    Assayag P; Charlemagne D; de Leiris J; Boucher F; Valère PE; Lortet S; Swynghedauw B; Besse S
    Hypertension; 1997 Jan; 29(1 Pt 1):15-21. PubMed ID: 9039074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.
    Douglas PS; Katz SE; Weinberg EO; Chen MH; Bishop SP; Lorell BH
    J Am Coll Cardiol; 1998 Oct; 32(4):1118-25. PubMed ID: 9768741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiac endothelin system in established pressure overload left ventricular hypertrophy.
    Schunkert H; Orzechowski HD; Böcker W; Meier R; Riegger GA; Paul M
    J Mol Med (Berl); 1999 Aug; 77(8):623-30. PubMed ID: 10543394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding.
    Feldman AM; Weinberg EO; Ray PE; Lorell BH
    Circ Res; 1993 Jul; 73(1):184-92. PubMed ID: 8508529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement.
    Petrov G; Dworatzek E; Schulze TM; Dandel M; Kararigas G; Mahmoodzadeh S; Knosalla C; Hetzer R; Regitz-Zagrosek V
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1073-80. PubMed ID: 25306541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-volume analysis reveals characteristic sex-related differences in cardiac function in a rat model of aortic banding-induced myocardial hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Loganathan S; Jiang W; Lehmann L; Oláh A; Sayour AA; Barta BA; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H502-H511. PubMed ID: 29799277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
    Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding.
    Schunkert H; Weinberg EO; Bruckschlegel G; Riegger AJ; Lorell BH
    J Clin Invest; 1995 Dec; 96(6):2768-74. PubMed ID: 8675646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy.
    Song LS; Pi Y; Kim SJ; Yatani A; Guatimosim S; Kudej RK; Zhang Q; Cheng H; Hittinger L; Ghaleh B; Vatner DE; Lederer WJ; Vatner SF
    Circ Res; 2005 Sep; 97(5):457-64. PubMed ID: 16051885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indapamide in rats with pressure overload left ventricular hypertrophy.
    Böcker W; Hupf H; Grimm D; Kurzidim K; Schunkert H
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):481-6. PubMed ID: 11026649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.
    Norton GR; Woodiwiss AJ; Gaasch WH; Mela T; Chung ES; Aurigemma GP; Meyer TE
    J Am Coll Cardiol; 2002 Feb; 39(4):664-71. PubMed ID: 11849866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.